- Home
- VKTX vs TFSL Comparison
VKTX vs TFSL Comparison
Compare VKTX & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- TFSL
- Stock Information
- Founded
- VKTX 2012
- TFSL 1938
- Country
- VKTX United States
- TFSL United States
- Employees
- VKTX N/A
- TFSL N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- TFSL Savings Institutions
- Sector
- VKTX Health Care
- TFSL Finance
- Exchange
- VKTX Nasdaq
- TFSL Nasdaq
- Market Cap
- VKTX 3.4B
- TFSL 3.9B
- IPO Year
- VKTX 2015
- TFSL 2007
- Fundamental
- Price
- VKTX $34.07
- TFSL $13.32
- Analyst Decision
- VKTX Strong Buy
- TFSL Hold
- Analyst Count
- VKTX 14
- TFSL 3
- Target Price
- VKTX $97.29
- TFSL $14.33
- AVG Volume (30 Days)
- VKTX 4.8M
- TFSL 255.4K
- Earning Date
- VKTX 02-05-2025
- TFSL 01-30-2025
- Dividend Yield
- VKTX N/A
- TFSL 8.42%
- EPS Growth
- VKTX N/A
- TFSL 14.86
- EPS
- VKTX N/A
- TFSL 0.29
- Revenue
- VKTX N/A
- TFSL $304,584,000.00
- Revenue This Year
- VKTX N/A
- TFSL N/A
- Revenue Next Year
- VKTX $986.87
- TFSL $5.53
- P/E Ratio
- VKTX N/A
- TFSL $46.73
- Revenue Growth
- VKTX N/A
- TFSL 0.99
- 52 Week Low
- VKTX $28.64
- TFSL $11.70
- 52 Week High
- VKTX $99.41
- TFSL $15.00
- Technical
- Relative Strength Index (RSI)
- VKTX 51.41
- TFSL 50.49
- Support Level
- VKTX $28.90
- TFSL $13.26
- Resistance Level
- VKTX $34.37
- TFSL $13.86
- Average True Range (ATR)
- VKTX 2.37
- TFSL 0.26
- MACD
- VKTX 0.66
- TFSL -0.03
- Stochastic Oscillator
- VKTX 70.06
- TFSL 8.82
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.